Search

Your search keyword '"Budczies Jan"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Budczies Jan" Remove constraint Author: "Budczies Jan" Publisher springer science and business media llc Remove constraint Publisher: springer science and business media llc
36 results on '"Budczies Jan"'

Search Results

1. KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma

2. Correction: Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer

3. Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients

4. Regulation (EU) 2017/746 (IVDR): practical implementation of annex I in pathology

5. Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis

6. Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer

7. Structure and content of the EU-IVDR

8. Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing

9. Struktur und Inhalt der EU-IVDR

10. Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma

12. Pre-operative cellular dissociation grading in biopsies is highly predictive of post-operative tumour stage and patient outcome in head and neck squamous cell carcinoma

14. Post-neoadjuvant cellular dissociation grading based on tumour budding and cell nest size is associated with therapy response and survival in oesophageal squamous cell carcinoma

16. Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII + IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico ring trial

24. Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression

26. Metabolomics of human breast cancer: new approaches for tumor typing and biomarker discovery

27. Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue – a GC-TOFMS based metabolomics study

30. Vascular endothelial growth factor C mRNA expression is a prognostic factor in epithelial ovarian cancer as detected by kinetic RT-PCR in formalin-fixed paraffin-embedded tissue

31. High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo

32. Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy

33. Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro

Catalog

Books, media, physical & digital resources